Skip to main content
Log in

Analysis of HPV genotype-specific concordance between EUROArray HPV and HPV 3.5 LCD-Array Kit in cervical samples of 163 patients

  • Gynecologic Oncology
  • Published:
Archives of Gynecology and Obstetrics Aims and scope Submit manuscript

Abstract

Purpose

Human papilloma virus (HPV) as the most common viral infection of the anogenital tract is highly associated with intraepithelial neoplasia and cancer of the cervix and other anogential regions. To date, 15 high-risk (HR-) HPV and 3 probably/possibly HR-HPVs have been found to be associated with cervical cancer. Therefore, a screening especially for HR-HPV by appropriate tests is important for detection of precancerous lesions to prevent cancer. The purpose of this study was to analyze prospectively the concordance of the EUROArray HPV genotyping assay (Euroimmun; EUROArray) and the HPV 3.5 LCD-Array Kit (Chipron; LCD-Array).

Methods

Liquid-based, clinician-collected cervical cytology samples (n = 163) from women undergoing cervical inspection at the dysplasia consultation in the colposcopy clinic at the Medical Center—University of Freiburg, Germany were analyzed. Genotype-specific agreement was assessed by Cohen’s kappa statistic and McNemar’s P value of significance between proportions.

Results

Seventeen of the HR-HPV genotypes included in both assays were detected in 42.3% and 38% of samples by EUROArray and by LCD-Array, respectively; i.e. an agreement of 92.0% and a kappa value of 0.83 could be proven between the EUROArray and the LCD-Array. In 50 of 72 samples, identical HR-HPV genotypes were analyzed (81.9%, κ = 0.47) and genotyping for HPV 16 and/or 18 was highly concordant in both tests (relative agreement 96.3%, κ = 0.88). Detection of any HR-HPV was not significantly different after comparison of EUROArray with LCD-Array.

Conclusion

Both of the tests showed comparable results for the detection of HPV in cervical specimens and permit these assays to be suitable for routine diagnostics.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Hartwig S, Baldauf JJ, Dominiak-Felden G, Simondon F, Alemany L, de Sanjose S, Castellsague X (2015) Estimation of the epidemiological burden of HPV-related anogenital cancers, precancerous lesions, and genital warts in women and men in Europe: potential additional benefit of a nine-valent second generation HPV vaccine compared to first generation HPV vaccines. Papillomavirus Res 1:90–100. https://doi.org/10.1016/j.pvr.2015.06.003

    Article  PubMed Central  Google Scholar 

  2. Hubbers CU, Akgul B (2015) HPV and cancer of the oral cavity. Virulence 6(3):244–248. https://doi.org/10.1080/21505594.2014.999570

    Article  PubMed  PubMed Central  Google Scholar 

  3. Munoz N, Bosch FX, de Sanjose S, Herrero R, Castellsague X, Shah KV, Snijders PJ, Meijer CJ, International Agency for Research on Cancer Multicenter Cervical Cancer Study G (2003) Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 348(6):518–527. https://doi.org/10.1056/NEJMoa021641

    Article  Google Scholar 

  4. IARC (2012) Human papillomaviruses. In: Biological agents. IARC Working Group on the Evaluation of Carcinogenic Risk to Humans, vol 100B, pp 1–441

  5. Munoz N, Bosch FX, Castellsague X, Diaz M, de Sanjose S, Hammouda D, Shah KV, Meijer CJ (2004) Against which human papillomavirus types shall we vaccinate and screen? The international perspective. Int J Cancer 111(2):278–285. https://doi.org/10.1002/ijc.20244

    Article  PubMed  Google Scholar 

  6. de Sanjose S, Quint WG, Alemany L, Geraets DT, Klaustermeier JE, Lloveras B, Tous S, Felix A, Bravo LE, Shin HR, Vallejos CS, de Ruiz PA, Lima MA, Guimera N, Clavero O, Alejo M, Llombart-Bosch A, Cheng-Yang C, Tatti SA, Kasamatsu E, Iljazovic E, Odida M, Prado R, Seoud M, Grce M, Usubutun A, Jain A, Suarez GA, Lombardi LE, Banjo A, Menendez C, Domingo EJ, Velasco J, Nessa A, Chichareon SC, Qiao YL, Lerma E, Garland SM, Sasagawa T, Ferrera A, Hammouda D, Mariani L, Pelayo A, Steiner I, Oliva E, Meijer CJ, Al-Jassar WF, Cruz E, Wright TC, Puras A, Llave CL, Tzardi M, Agorastos T, Garcia-Barriola V, Clavel C, Ordi J, Andujar M, Castellsague X, Sanchez GI, Nowakowski AM, Bornstein J, Munoz N, Bosch FX, Retrospective International S, Group HPVTTS (2010) Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study. Lancet Oncol 11(11):1048–1056. https://doi.org/10.1016/S1470-2045(10)70230-8

    Article  PubMed  Google Scholar 

  7. Poljak M, Kocjan BJ, Ostrbenk A, Seme K (2016) Commercially available molecular tests for human papillomaviruses (HPV): 2015 update. J Clin Virol 76(Suppl 1):S3–S13. https://doi.org/10.1016/j.jcv.2015.10.023

    Article  PubMed  Google Scholar 

  8. Saslow D, Solomon D, Lawson HW, Killackey M, Kulasingam SL, Cain J, Garcia FA, Moriarty AT, Waxman AG, Wilbur DC, Wentzensen N, Downs LS Jr, Spitzer M, Moscicki AB, Franco EL, Stoler MH, Schiffman M, Castle PE, Myers ER, Committee A-A-ACCG (2012) American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer. CA Cancer J Clin 62(3):147–172. https://doi.org/10.3322/caac.21139

    Article  PubMed  PubMed Central  Google Scholar 

  9. Santesso N, Mustafa RA, Schunemann HJ, Arbyn M, Blumenthal PD, Cain J, Chirenje M, Denny L, De Vuyst H, Eckert LO, Forhan SE, Franco EL, Gage JC, Garcia F, Herrero R, Jeronimo J, Lu ER, Luciani S, Quek SC, Sankaranarayanan R, Tsu V, Broutet N, Guideline Support G (2016) World Health Organization Guidelines for treatment of cervical intraepithelial neoplasia 2–3 and screen-and-treat strategies to prevent cervical cancer. Int J Gynaecol Obstet 132(3):252–258. https://doi.org/10.1016/j.ijgo.2015.07.038

    Article  PubMed  Google Scholar 

  10. DKG D, AWMF (2017) S3-Leitlinie Prävention des Zervixkarzinoms. https://www.awmf.org/uploads/tx_szleitlinien/015-027OLl_Praevention_Zervixkarzinom_2018-01.pdf

  11. Castle PE, Gravitt PE, Solomon D, Wheeler CM, Schiffman M (2008) Comparison of linear array and line blot assay for detection of human papillomavirus and diagnosis of cervical precancer and cancer in the atypical squamous cell of undetermined significance and low-grade squamous intraepithelial lesion triage study. J Clin Microbiol 46(1):109–117. https://doi.org/10.1128/JCM.01667-07

    Article  PubMed  Google Scholar 

  12. Cox JT, Lorincz AT, Schiffman MH, Sherman ME, Cullen A, Kurman RJ (1995) Human papillomavirus testing by hybrid capture appears to be useful in triaging women with a cytologic diagnosis of atypical squamous cells of undetermined significance. Am J Obstet Gynecol 172(3):946–954

    Article  PubMed  Google Scholar 

  13. Liu SS, Leung RC, Chan KK, Cheung AN, Ngan HY (2010) Evaluation of a newly developed GenoArray human papillomavirus (HPV) genotyping assay and comparison with the Roche Linear Array HPV genotyping assay. J Clin Microbiol 48(3):758–764. https://doi.org/10.1128/JCM.00989-09

    Article  PubMed  Google Scholar 

  14. Stoler MH, Castle PE, Solomon D, Schiffman M, American Society for C, Cervical P (2007) The expanded use of HPV testing in gynecologic practice per ASCCP-guided management requires the use of well-validated assays. Am J Clin Pathol 127(3):335–337. https://doi.org/10.1309/RNF3C01JKADQCLKP

    Article  Google Scholar 

  15. Wang L, Wang P, Ren Y, Du J, Jiang J, Jia X, Chen C, Wang Y (2016) Prevalence of high-risk human papillomavirus (HR-HPV) genotypes and multiple infections in cervical abnormalities from northern Xinjiang, China. PLoS ONE 11(8):e0160698. https://doi.org/10.1371/journal.pone.0160698

    Article  PubMed  PubMed Central  Google Scholar 

  16. Cornall AM, Poljak M, Garland SM, Phillips S, Machalek DA, Tan JH, Quinn MA, Tabrizi SN (2017) HPV genotype-specific concordance between EuroArray HPV, Anyplex II HPV28 and Linear Array HPV Genotyping test in Australian cervical samples. Papillomavirus Res 4:79–84. https://doi.org/10.1016/j.pvr.2017.10.002

    Article  PubMed  PubMed Central  Google Scholar 

  17. Latsuzbaia A, Tapp J, Nguyen T, Fischer M, Arbyn M, Weyers S, Mossong J (2016) Analytical performance evaluation of Anyplex II HPV28 and Euroarray HPV for genotyping of cervical samples. Diagn Microbiol Infect Dis 85(3):318–322. https://doi.org/10.1016/j.diagmicrobio.2016.04.011

    Article  PubMed  Google Scholar 

  18. Viti J, Poljak M, Ostrbenk A, Bhatia R, Alcaniz Boada E, Cornall AM, Cuschieri K, Garland S, Xu L, Arbyn M (2018) Validation of EUROArray HPV test using the VALGENT framework. J Clin Virol 108:38–42. https://doi.org/10.1016/j.jcv.2018.09.005

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.

Author information

Authors and Affiliations

Authors

Contributions

KB: data analysis, manuscript writing. CE, VS, MK: data collection or management. SB, FK, AR, MK: manuscript editing. MP: protocol/project development, manuscript editing.

Corresponding author

Correspondence to Karen Bräutigam.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee [local ethics committee of Freiburg University (10013/19)] and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.

Informed consent

Informed consent was obtained from all individual participants included in the study.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bräutigam, K., Ehret, C., Schillinger, V. et al. Analysis of HPV genotype-specific concordance between EUROArray HPV and HPV 3.5 LCD-Array Kit in cervical samples of 163 patients. Arch Gynecol Obstet 301, 745–751 (2020). https://doi.org/10.1007/s00404-019-05427-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00404-019-05427-y

Keywords

Navigation